Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis

NCT02364986 is registered in ClinicalTrials.gov with PD Dr. Marcus Müller as lead sponsor.

NCT NCT02364986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02364986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis
Lead sponsor
PD Dr. Marcus Müller
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2015
Completion date
January 31, 2017
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis